Case of ketoacidosis by a sodium-glucose cotransporter 2 inhibitor in a diabetic patient with a low-carbohydrate diet
For years, the gold standard in GLP-1 receptor agonist therapythe class of drugs that includes Ozempic and Wegovyhas been an injectable medication
[DOI] [PubMed] [Google Scholar] 81.Donini L.M., Busetto L., Bischoff S.C., Cederholm T., Ballesteros-Pomar M.D., Batsis J.A., Bauer J.M., Boirie Y., Cruz-Jentoft A.J., Dicker D., et al
Watch: Weight Loss Pills Are Back In this video, we explain why oral medication is receiving renewed attentionand why pills are only one part of modern, personalized obesity care
Yes, but with some considerations regarding potential adverse events
Early research suggests retatrutide produces greater weight loss than semaglutide